11.28.12
Naturex, Avignon, France, proprietary studies demonstrated that Fraxinus excelsior seed extract, commonly known as “common ash” or “European ash”, exhibited potent anti-hyperglycemic activities, and as a result was awarded U.S. Patent Number: 8,293,292 “Extract of Fraxinus Excelsior seeds and therapeutic applications therefor.” The patent application covers the glycemia regulation activity of the company’s product FraxiPure, as well as the extraction and characterization of new secoiridoid compounds. The Naturex team of research scientists discovered these new components by using highly sophisticated analytical methods, including nuclear magnetic resonance (NMR) and mass spectroscopy (MS).